Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WOKVAC vaccine in breast cancer
NCT02780401Phase 1Completed
- Sponsor
- University of Washington
- Start
- Sep 2016
- Primary completion
- Oct 2020
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of WOKVAC in breast cancer, sponsored by University of Washington. Primary endpoint: Number of Adverse Events Per Common Terminology Criteria for Adverse Events Version 4.0 up to 9 months. Started Sep 2016; status: completed.
02
Drugs
WOKVAC
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02780401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02780401.